479 related articles for article (PubMed ID: 33391492)
21. Extracellular Vesicles Derived from Glioma Stem Cells Affect Glycometabolic Reprogramming of Glioma Cells Through the miR-10b-5p/PTEN/PI3K/Akt Pathway.
Li S; Mao L; Song L; Xia X; Wang Z; Cheng Y; Lai J; Tang X; Chen X
Stem Cell Rev Rep; 2024 Apr; 20(3):779-796. PubMed ID: 38294721
[TBL] [Abstract][Full Text] [Related]
22. Telomestatin impairs glioma stem cell survival and growth through the disruption of telomeric G-quadruplex and inhibition of the proto-oncogene, c-Myb.
Miyazaki T; Pan Y; Joshi K; Purohit D; Hu B; Demir H; Mazumder S; Okabe S; Yamori T; Viapiano M; Shin-ya K; Seimiya H; Nakano I
Clin Cancer Res; 2012 Mar; 18(5):1268-80. PubMed ID: 22230766
[TBL] [Abstract][Full Text] [Related]
23. ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma.
Tong L; Li J; Li Q; Wang X; Medikonda R; Zhao T; Li T; Ma H; Yi L; Liu P; Xie Y; Choi J; Yu S; Lin Y; Dong J; Huang Q; Jin X; Lim M; Yang X
Theranostics; 2020; 10(13):5943-5956. PubMed ID: 32483429
[TBL] [Abstract][Full Text] [Related]
24. Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells.
Shingu T; Holmes L; Henry V; Wang Q; Latha K; Gururaj AE; Gibson LA; Doucette T; Lang FF; Rao G; Yuan L; Sulman EP; Farrell NP; Priebe W; Hess KR; Wang YA; Hu J; Bögler O
J Transl Med; 2016 Feb; 14():46. PubMed ID: 26861698
[TBL] [Abstract][Full Text] [Related]
25. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
26. Molecular Characterization of AEBP1 at Transcriptional Level in Glioma.
Wang K; Huang R; Tong X; Wang Z; Sun S; Wu C
Biomed Res Int; 2021; 2021():5579359. PubMed ID: 34373835
[TBL] [Abstract][Full Text] [Related]
27. A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells.
Kanai R; Wakimoto H; Martuza RL; Rabkin SD
Clin Cancer Res; 2011 Jun; 17(11):3686-96. PubMed ID: 21505062
[TBL] [Abstract][Full Text] [Related]
28. BRCA1-associated protein inhibits glioma cell proliferation and migration and glioma stem cell self-renewal via the TGF-β/PI3K/AKT/mTOR signalling pathway.
Wang B; Cao C; Liu X; He X; Zhuang H; Wang D; Chen B
Cell Oncol (Dordr); 2020 Apr; 43(2):223-235. PubMed ID: 31776938
[TBL] [Abstract][Full Text] [Related]
29. Paracaspase MALT1 regulates glioma cell survival by controlling endo-lysosome homeostasis.
Jacobs KA; André-Grégoire G; Maghe C; Thys A; Li Y; Harford-Wright E; Trillet K; Douanne T; Alves Nicolau C; Frénel JS; Bidère N; Gavard J
EMBO J; 2020 Jan; 39(1):e102030. PubMed ID: 31774199
[TBL] [Abstract][Full Text] [Related]
30. miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1.
Guo H; Nan Y; Zhen Y; Zhang Y; Guo L; Yu K; Huang Q; Zhong Y
Tumour Biol; 2016 Oct; 37(10):13751-13761. PubMed ID: 27476171
[TBL] [Abstract][Full Text] [Related]
31. LncRNA-XIST/microRNA-126 sponge mediates cell proliferation and glucose metabolism through the IRS1/PI3K/Akt pathway in glioma.
Cheng Z; Luo C; Guo Z
J Cell Biochem; 2020 Mar; 121(3):2170-2183. PubMed ID: 31680298
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas.
Canella A; Welker AM; Yoo JY; Xu J; Abas FS; Kesanakurti D; Nagarajan P; Beattie CE; Sulman EP; Liu J; Gumin J; Lang FF; Gurcan MN; Kaur B; Sampath D; Puduvalli VK
Clin Cancer Res; 2017 Oct; 23(20):6215-6226. PubMed ID: 28679777
[No Abstract] [Full Text] [Related]
33. Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells.
Daniele S; Costa B; Zappelli E; Da Pozzo E; Sestito S; Nesi G; Campiglia P; Marinelli L; Novellino E; Rapposelli S; Martini C
Sci Rep; 2015 Apr; 5():9956. PubMed ID: 25898313
[TBL] [Abstract][Full Text] [Related]
34. The U2AF2 /circRNA ARF1/miR-342-3p/ISL2 feedback loop regulates angiogenesis in glioma stem cells.
Jiang Y; Zhou J; Zhao J; Zhang H; Li L; Li H; Chen L; Hu J; Zheng W; Jing Z
J Exp Clin Cancer Res; 2020 Sep; 39(1):182. PubMed ID: 32894165
[TBL] [Abstract][Full Text] [Related]
35. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
36. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.
Zhang L; Zhang W; Li Y; Alvarez A; Li Z; Wang Y; Song L; Lv D; Nakano I; Hu B; Cheng SY; Feng H
Oncogene; 2016 Oct; 35(43):5641-5652. PubMed ID: 27041571
[TBL] [Abstract][Full Text] [Related]
37. SENP1-Mediated deSUMOylation Regulates the Tumor Remodeling of Glioma Stem Cells Under Hypoxic Stress.
Wen P; Li H; Liu L; Liu X; Xu Z; Dong J
Technol Cancer Res Treat; 2024; 23():15330338241257490. PubMed ID: 38803001
[No Abstract] [Full Text] [Related]
38. The Radiosensitizing Effect of AZD0530 in Glioblastoma and Glioblastoma Stem-Like Cells.
Yun HS; Lee J; Kil WJ; Kramp TR; Tofilon PJ; Camphausen K
Mol Cancer Ther; 2021 Sep; 20(9):1672-1679. PubMed ID: 34158343
[TBL] [Abstract][Full Text] [Related]
39. Hypoxic Glioma Stem Cell-Derived Exosomes Containing Linc01060 Promote Progression of Glioma by Regulating the MZF1/c-Myc/HIF1α Axis.
Li J; Liao T; Liu H; Yuan H; Ouyang T; Wang J; Chai S; Li J; Chen J; Li X; Zhao H; Xiong N
Cancer Res; 2021 Jan; 81(1):114-128. PubMed ID: 33158815
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ
Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
